Brief: SkinBioTherapeutics Says Chairman And Non-Exec Director, Both Stepped Down From Board Today
BRIEF-SkinBioTherapeutics Says Chairman And Non-Exec Director, Both Stepped Down From Board Today June 8 (Reuters) - SkinBioTherapeutics PLC SBTX.L:
SKINBIOTHERAPEUTICS - HALF-YEAR RESULTS (HY26) AND RESTATED FY25 RESULTS
SKINBIOTHERAPEUTICS PLC: COSTS OF BOARD INVESTIGATION ARE IN AGGREGATE C.£0.7M.
SKINBIOTHERAPEUTICS PLC: WILL BE PURSUING RECOVERY OF COSTS INCURRED IN CONNECTION WITH INVESTIGATION
SKINBIOTHERAPEUTICS PLC: BOARD IS COMMITTED TO ISSUING NEW MARKET GUIDANCE AND WILL DO SO LATER IN YEAR
SKINBIOTHERAPEUTICS PLC: MARTIN HUNT, CHAIRMAN, CATHY PRESCOTT, NON-EXEC DIRECTOR, HAVE BOTH STEPPED DOWN FROM BOARD TODAY
SKINBIOTHERAPEUTICS - ALYSON LEVETT APPOINTED INTERIM CHAIR
SKINBIOTHERAPEUTICS - RESTATES FY25 AUDITED REVENUE TO £3.87M FROM £4.64M
SKINBIOTHERAPEUTICS - HY26 REVENUES UP 37.4% TO £2.17M
Source text: ID:nRSH3646Ha
Further company coverage: SBTX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Says Chairman And Non-Exec Director, Both Stepped Down From Board Today
SkinBioTherapeutics - Half-year Results (HY26) and Restated FY25 Results
SkinBioTherapeutics - Holding(s) in Company
SkinBioTherapeutics OptiBiotix Health - Holding(s) in Company
Brief: Skinbiotherapeutics To Finalise Hy26 Results With Restated Fy25 Results After Investigation Review